Zusammenfassung
Hintergrund
25 Antibiotika einschließlich der neuen Fluorchinolone Levofloxacin, Gatifloxacin und Moxifloxacin wurden gegenüber der bakteriellen Normalflora der Bindehaut getestet.
Patienten und Methoden
Es wurden Bindehautabstriche bei insgesamt 160 Patienten (Median: 74 Jahre, Mittelwert: 71 Jahre) der Universitätsaugenklinik Stanford/USA vor Kataraktoperation abgenommen. Die daraus kultivierten Bakterienstämme wurden auf ihre antibiotische In-vitro-Empfindlichkeit mit dem Agardiffusionstest nach Kirby-Bauer getestet.
Ergebnisse
Von 256 isolierten Bakterienstämmen waren 201 (79%) koagulasenegative Staphylokokken (KNS), 26 Staphylococcus aureus, 15 Streptokokken der Gruppe D sowie 14 gramnegative Stäbchen. 100 der 256 Stämme (39%) wurden als multiresistent (resistent gegen mehr als 5 Antibiotika) eingestuft. Die aufsteigende Reihenfolge der Resistenzrate (RR) der KNS betrug: Gatifloxacin=Moxifloxacin<Gentamycin=Tobramycin=Levofloxacin=Neomycin<Ciprofloxacin=Ofloxacin<Erythromycin. Die RR von Staphylococcus aureus und der gramnegativen Stäbchen war niedrig und wies bezüglich der getesteten Antibiotika untereinander keine signifikanten Unterschiede auf. Die Streptokokken der Gruppe D wiesen insgesamt eine hohe Resistenzrate (RR über 30%) gegenüber den Antibiotika mit Ausnahme von Gatifloxacin, Levofloxacin oder Moxifloxacin auf. Bei allen Bakterien wurden hohe Resistenzraten (50%) gegenüber Erythromycin nachgewiesen.
Schlussfolgerungen
Trotz einer hohen Prävalenz multiresistenter Bakterienstämme zeigten die Fluorchinolone der neuen Generation eine außerordentlich hohe Wirksamkeit gegenüber den koagulasenegativen Staphylokokken und den Streptokokken der Gruppe D.
Abstract
Background
Our aim was to determine the antibiotic susceptibility of the preoperative conjunctival bacterial flora against 25 commonly used antibiotics, especially the new fluoroquinolones levofloxacin, gatifloxacin, and moxifloxacin.
Patients and Methods
The Kirby-Bauer disk-diffusion technique was used to test for the in vitro antibiotic susceptibility of conjunctival bacterial strains isolated from 160 patients (median=74 years, mean=71 years) undergoing cataract surgery at the Department of Ophthalmology, Stanford University, CA, USA.
Results
Among the 256 bacteria isolated, 201 (79%) were coagulase-negative staphylococci (CNS), 26 Staphylococcus aureus, 15 Streptococcus group D and 14 gram-negative rods. A total of 100 of these 256 strains (39%) were classified as multiresitant (resistant to ≥ five antibiotics). The resistance rate (RR) of commonly used antibiotics for all CNS was: gatifloxacin=moxifloxacin<gentamycin=tobramycin=levofloxacin=neomycin<ciprofloxacin=ofloxacin<erythromycin. The RR for S. aureus and the gram-negative rods was low and insignificant in comparison to the other antibiotics tested. None of the Streptococcus group D were resistant to gatifloxacin, levofloxacin, or moxifloxacin, however, they were highly resistant (RR over 30%) to the other antibiotics. Some 50% of the bacteria were resistant to erythromycin.
Conclusion
Newer generation fluoroquinolones provide excellent efficacy against coagulase-negative staphylococci and Streptococcus group D despite a high number of multiresitant bacteria.
Literatur
Alexandrakis G, Alfonso EC,Miller D (2000) Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology 107: 1497–502
Barry P, Seal DV, Gettinby G et al. (2006) ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study. J Cataract Refract Surg 32: 407–410
Bauer AW, Kirby WM, Sherris JC et al. (1966) Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45: 493–496
Ciulla TA, Starr MB, Masket S (2002) Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology 109: 13–24
Drlica K (1999) Mechanism of fluoroquinolone action. Curr Opin Microbiol 2: 504–508
Drlica K (2000) The future of fluoroquinolones. Ann Med 32: 585–587
Drlica K,Malik M (2003) Fluoroquinolones: action and resistance. Curr Top Med Chem 3: 249–282
Garcia-Saenz MC,Arias-Puente A,Fresnadillo-Martinez MJ,Carrasco-Font C (2001) Human aqueous humor levels of oral ciprofloxacin, levofloxacin, and moxifloxacin. J Cataract Refract Surg 27: 1969–1974
Goldstein MH, Kowalski RP, Gordon YJ (1999) Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Ophthalmology 106: 1313–1318
Grasbon T, Mino de Kaspar H, Klauss V (1995) [Coagulase-negative staphylococci in normal and chronically inflamed conjunctiva]. Ophthalmologe 92: 793–801
Graves A, Henry M, O’Brien TP et al. (2001) In vitro susceptibilities of bacterial ocular isolates to fluoroquinolones. Cornea 20: 301–305
Huebner J, Goldmann DA (1999) Coagulase-negative staphylococci: role as pathogens. Annu Rev Med 50: 223–236
Karow T, Lang R (2001) Antibiotika. Journal 533–567
Kowalski RP, Romanowski EG,Yates KA et al. (2001) Lomefloxacin is an effective treatment of experimental bacterial keratitis. Cornea 20: 306–308
Kowalski RP, Yates KA, Romanowski EG et al. (2005) An ophthalmologist’s guide to understanding antibiotic susceptibility and minimum inhibitory concentration data. Ophthalmology 112: 1987
Kurokawa N, Hayashi K, Konishi M et al. (2002) Increasing ofloxacin resistance of bacterial flora from conjunctival sac of preoperative ophthalmic patients in Japan. Jpn J Ophthalmol 46: 586–589
Leong JK, Shah R, McCluskey PJ et al. (2002) Bacterial contamination of the anterior chamber during phacoemulsification cataract surgery. J Cataract Refract Surg 28: 826–833
Liesegang TJ (2001) Use of antimicrobials to prevent postoperative infection in patients with cataracts. Curr Opin Ophthalmol 12: 68–74
Marians KJ, Hiasa H (1997) Mechanism of quinolone action. A drug-induced structural perturbation of the DNA precedes strand cleavage by topoisomerase IV. J Biol Chem 272: 9401–9409
Masket S (1998) Preventing, diagnosing, and treating endophthalmitis. J Cataract Refract Surg 24: 725–726
Mather R, Karenchak LM, Romanowski EG et al. (2002) Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 133: 463–466
Mino De Kaspar H, Kollmann M, Klauss V (1993) Endophthalmitis; Bedeutung mikrobiologischer Untersuchungen für Therapie und Prognose. Ophthalmologe 90: 726–7336
Mino de Kaspar H, Koss MJ, He L et al. (2005) Antibiotic susceptibility of preoperative normal conjunctival bacteria. Am J Ophthalmol 139: 730–733
Mino de Kaspar H, Neubauer AS, Molnar A et al. (2002) Rapid direct antibiotic susceptibility testing in endophthalmitis. Ophthalmology 109: 687–693
Mino De Kaspar H, Hoepfner AS, Engelbert M et al. (2001) Antibiotic resistance pattern and visual outcome in experimentally-induced Staphylococcus epidermidis endophthalmitis in a rabbit model. Ophthalmology 108: 470–478
Pinna A, Sechi LA, Zanetti S et al. (2001) Bacillus cereus keratitis associated with contact lens wear. Ophthalmology 108: 1830–1804
Schaefer F, Bruttin O, Zografos L et al. (2001) Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol 85: 842–847
Speaker MG, Milch FA, Shah MK et al. (1991) Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 98: 639–49; discussion 650
Standards NCfCL (2000) Methods for dilution antimicrobials susceptibility tests for bacteria that grow aerobiacally. Journal 20: approved standard (document M7-A5)
Ta CN, He L, Nguyen E et al. (2006) Prospective randomized study determining whether a 3-day application of ofloxacin results in the selection of fluoroquinolone-resistant coagulase-negative Staphylococcus. Eur J Ophthalmol 16: 359–364
Ta CN, Egbert PR, Singh K et al. (2002) Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery. Ophthalmology 109: 2036–40; discussion 2040–2041
Ta CN, Chang RT, Singh K et al. (2003) Antibiotic resistance patterns of ocular bacterial flora: a prospective study of patients undergoing anterior segment surgery. Ophthalmology 110: 1946–1951
Tenover F, Hughes J (1996) The challenge of emerging infectious diseases: development and spread of multiply-resistant bacterial pathogens. JAMA 300–304
Willmott CJ, Maxwell A (1993) A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex. Antimicrob Agents Chemother 37: 126–127
Yamada M, Mochizuki H, Yamada K et al. (2002) Aqueous humor levels of topically applied levofloxacin in human eyes. Curr Eye Res 24: 403–406
Yolton JD (2001) Antiinfective Drugs. Journal 11: 219–264
Interessenkonflikt
Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.
Author information
Authors and Affiliations
Corresponding author
Additional information
Vorgetragen als Paperbeitrag auf dem Jahreskongress der Deutschen Ophthalmologischen Gesellschaft (DOG) 2005, Berlin
Teile der Arbeit wurden bereits publiziert [23].
Rights and permissions
About this article
Cite this article
Koss, M.J., Eder, M., Blumenkranz, M.S. et al. Wirksamkeit neuer Fluorchinolone gegenüber der bakteriellen Normalflora der Bindehaut. Ophthalmologe 104, 21–27 (2007). https://doi.org/10.1007/s00347-006-1453-1
Issue Date:
DOI: https://doi.org/10.1007/s00347-006-1453-1